Showing results (71-80 of 274) with videos related to
Sort By:
Pageof 28
Cancer Chemotherapy and Pharmacology|May 20, 2026
Enhancing triapine treatment: strategies for dose optimization and methemoglobin level mitigationHeekyung Lee, Allison Dunn, Sarah E Taylor, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 19, 2016
The Effect of Hepatic Impairment on Outcomes in Phase I Clinical Trials in Cancer SubjectsAaron S Mansfield, Michelle A Rudek, Diana Vulih, et al.Nature Reviews. Drug Discovery|September 5, 2002
Clinical proteomics: translating benchside promise into bedside realityEmanuel F Petricoin, Kathryn C Zoon, Elise C Kohn, et al.Molecular & Cellular Proteomics : MCP|June 2, 2006
Proteomics in clinical trials and practice: present uses and future promiseNilofer S Azad, Nabila Rasool, Christina M Annunziata, et al.Cancer Research|May 4, 2005
Supra-additive growth inhibition by a celecoxib analogue and carboxyamido-triazole is primarily mediated through apoptosisMary E Winters, Arpita I Mehta, Emanuel F Petricoin, et al.Cancer Detection and Prevention|November 15, 2002
Genomics and proteomics: application of novel technology to early detection and prevention of cancerChad M Michener, Ali M Ardekani, Emmanuel F Petricoin, et al.Cancer Science|September 6, 2007
Targeted optical fluorescence imaging of human ovarian adenocarcinoma using a galactosyl serum albumin-conjugated fluorophoreAndrew J Gunn, Yukihiro Hama, Yoshinori Koyama, et al.Investigative Ophthalmology & Visual Science|September 29, 2004
CAI is a potent inhibitor of neovascularization and imparts neuroprotection in a mouse model of ischemic retinopathyAlan J Franklin, Tom L Jetton, C Lynn Kuchemann, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 3, 2017
Challenges and Opportunities in Adapting Clinical Trial Design for ImmunotherapiesLillian L Siu, S Percy Ivy, Erica L Dixon, et al.Journal of Cellular Physiology|August 28, 2003
Regulation of the pro-angiogenic microenvironment by carboxyamido-triazoleVyta Kulpa Oliver, Angela M Patton, Sudhen Desai, et al.Pageof 28